Hyderabad: Ocugen Inc and Bharat Biotech on Tuesday announced they have entered into a definitive agreement to co-develop, supply and commercialise Bharat Biotech’s Covaxin, an advanced stage whole-virion inactivated Covid-19 vaccine candidate, for the United States market. Ocugen, a biopharmaceutical company focused on discovering, developing, and commercialising gene therapies to cure blindness diseases and developing a […] The post Bharat Biotech, Ocugen Ink Deal For Supply Of Covaxin To US appeared first on Ommcom News.
Hence then, the article about bharat biotech ocugen ink deal for supply of covaxin to us was published today ( ) and is available onOmmcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Bharat Biotech, Ocugen Ink Deal For Supply Of Covaxin To US )